,address1,address2,city,state,zip,country,phone,fax,website,industry,sector,longBusinessSummary,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,openInterest,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,Building 191,Murdoch University 90 South Street,Murdoch,WA,6150,Australia,61 8 9360 2888,61 8 9360 2899,https://orthocell.com,Biotechnology,Healthcare,"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.","{'maxAge': 1, 'name': 'Mr. Paul Frederick Anderson', 'age': 56, 'title': 'CEO, MD & Exec. Director', 'yearBorn': 1966, 'fiscalYear': 2023, 'totalPay': 650974, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.37,0.37,0.365,0.37,0.37,0.37,0.365,0.37,0.0,0.182807,-7.3,24914,24914,136196,114299,114299,0.36,0.375,0,0,73002192,0,0.32,0.505,17.205044,0.3799,0.3846125,0.0,0.0,AUD,47759964,-1.4725599,152706658,197303008,0.23173,0.02912,0.031,11.774194,1688083200,1719705600,1688083200,-6248181,-0.03,-0.05,11.256,-4.812,ASX,EQUITY,OCC.AX,OCC.AX,ORTHOCELL FPO,Orthocell Limited,1407801600,Australia/Sydney,AEST,36000000,0.365,2.0,buy,24817962,0.126,-9925147,562305,5.664,5.93,4243069,9.145,0.022,-0.19037001,-0.77841,3216914,15835941,14592580,3.424,0.75816,-2.33914,-2.42279,AUD,
1,Building 191,Murdoch University 90 South Street,Murdoch,WA,6150,Australia,61 8 9360 2888,61 8 9360 2899,https://orthocell.com,Biotechnology,Healthcare,"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.","{'maxAge': 1, 'name': 'Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D.', 'age': 52, 'title': 'Exec. Director', 'yearBorn': 1970, 'fiscalYear': 2023, 'totalPay': 143750, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.37,0.37,0.365,0.37,0.37,0.37,0.365,0.37,0.0,0.182807,-7.3,24914,24914,136196,114299,114299,0.36,0.375,0,0,73002192,0,0.32,0.505,17.205044,0.3799,0.3846125,0.0,0.0,AUD,47759964,-1.4725599,152706658,197303008,0.23173,0.02912,0.031,11.774194,1688083200,1719705600,1688083200,-6248181,-0.03,-0.05,11.256,-4.812,ASX,EQUITY,OCC.AX,OCC.AX,ORTHOCELL FPO,Orthocell Limited,1407801600,Australia/Sydney,AEST,36000000,0.365,2.0,buy,24817962,0.126,-9925147,562305,5.664,5.93,4243069,9.145,0.022,-0.19037001,-0.77841,3216914,15835941,14592580,3.424,0.75816,-2.33914,-2.42279,AUD,
2,Building 191,Murdoch University 90 South Street,Murdoch,WA,6150,Australia,61 8 9360 2888,61 8 9360 2899,https://orthocell.com,Biotechnology,Healthcare,"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.","{'maxAge': 1, 'name': 'Ms. Leslie  Wise J.D.', 'title': 'Exec. Director', 'fiscalYear': 2023, 'totalPay': 73063, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.37,0.37,0.365,0.37,0.37,0.37,0.365,0.37,0.0,0.182807,-7.3,24914,24914,136196,114299,114299,0.36,0.375,0,0,73002192,0,0.32,0.505,17.205044,0.3799,0.3846125,0.0,0.0,AUD,47759964,-1.4725599,152706658,197303008,0.23173,0.02912,0.031,11.774194,1688083200,1719705600,1688083200,-6248181,-0.03,-0.05,11.256,-4.812,ASX,EQUITY,OCC.AX,OCC.AX,ORTHOCELL FPO,Orthocell Limited,1407801600,Australia/Sydney,AEST,36000000,0.365,2.0,buy,24817962,0.126,-9925147,562305,5.664,5.93,4243069,9.145,0.022,-0.19037001,-0.77841,3216914,15835941,14592580,3.424,0.75816,-2.33914,-2.42279,AUD,
3,Building 191,Murdoch University 90 South Street,Murdoch,WA,6150,Australia,61 8 9360 2888,61 8 9360 2899,https://orthocell.com,Biotechnology,Healthcare,"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.","{'maxAge': 1, 'name': 'Ms. Nicole Jane Telford', 'title': 'Chief Financial Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.37,0.37,0.365,0.37,0.37,0.37,0.365,0.37,0.0,0.182807,-7.3,24914,24914,136196,114299,114299,0.36,0.375,0,0,73002192,0,0.32,0.505,17.205044,0.3799,0.3846125,0.0,0.0,AUD,47759964,-1.4725599,152706658,197303008,0.23173,0.02912,0.031,11.774194,1688083200,1719705600,1688083200,-6248181,-0.03,-0.05,11.256,-4.812,ASX,EQUITY,OCC.AX,OCC.AX,ORTHOCELL FPO,Orthocell Limited,1407801600,Australia/Sydney,AEST,36000000,0.365,2.0,buy,24817962,0.126,-9925147,562305,5.664,5.93,4243069,9.145,0.022,-0.19037001,-0.77841,3216914,15835941,14592580,3.424,0.75816,-2.33914,-2.42279,AUD,
4,Building 191,Murdoch University 90 South Street,Murdoch,WA,6150,Australia,61 8 9360 2888,61 8 9360 2899,https://orthocell.com,Biotechnology,Healthcare,"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.","{'maxAge': 1, 'name': 'Mr. Alex  McHenry', 'title': 'Chief Operating Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.37,0.37,0.365,0.37,0.37,0.37,0.365,0.37,0.0,0.182807,-7.3,24914,24914,136196,114299,114299,0.36,0.375,0,0,73002192,0,0.32,0.505,17.205044,0.3799,0.3846125,0.0,0.0,AUD,47759964,-1.4725599,152706658,197303008,0.23173,0.02912,0.031,11.774194,1688083200,1719705600,1688083200,-6248181,-0.03,-0.05,11.256,-4.812,ASX,EQUITY,OCC.AX,OCC.AX,ORTHOCELL FPO,Orthocell Limited,1407801600,Australia/Sydney,AEST,36000000,0.365,2.0,buy,24817962,0.126,-9925147,562305,5.664,5.93,4243069,9.145,0.022,-0.19037001,-0.77841,3216914,15835941,14592580,3.424,0.75816,-2.33914,-2.42279,AUD,
5,Building 191,Murdoch University 90 South Street,Murdoch,WA,6150,Australia,61 8 9360 2888,61 8 9360 2899,https://orthocell.com,Biotechnology,Healthcare,"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.","{'maxAge': 1, 'name': 'Prof. Ming Hao  Zheng', 'title': 'Chief Scientific Officer and Member of Medical & Scientific Advisory Board', 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.37,0.37,0.365,0.37,0.37,0.37,0.365,0.37,0.0,0.182807,-7.3,24914,24914,136196,114299,114299,0.36,0.375,0,0,73002192,0,0.32,0.505,17.205044,0.3799,0.3846125,0.0,0.0,AUD,47759964,-1.4725599,152706658,197303008,0.23173,0.02912,0.031,11.774194,1688083200,1719705600,1688083200,-6248181,-0.03,-0.05,11.256,-4.812,ASX,EQUITY,OCC.AX,OCC.AX,ORTHOCELL FPO,Orthocell Limited,1407801600,Australia/Sydney,AEST,36000000,0.365,2.0,buy,24817962,0.126,-9925147,562305,5.664,5.93,4243069,9.145,0.022,-0.19037001,-0.77841,3216914,15835941,14592580,3.424,0.75816,-2.33914,-2.42279,AUD,
6,Building 191,Murdoch University 90 South Street,Murdoch,WA,6150,Australia,61 8 9360 2888,61 8 9360 2899,https://orthocell.com,Biotechnology,Healthcare,"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.","{'maxAge': 1, 'name': 'Mr. Tony  Macintrye', 'title': 'Chief Manufacturing Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.37,0.37,0.365,0.37,0.37,0.37,0.365,0.37,0.0,0.182807,-7.3,24914,24914,136196,114299,114299,0.36,0.375,0,0,73002192,0,0.32,0.505,17.205044,0.3799,0.3846125,0.0,0.0,AUD,47759964,-1.4725599,152706658,197303008,0.23173,0.02912,0.031,11.774194,1688083200,1719705600,1688083200,-6248181,-0.03,-0.05,11.256,-4.812,ASX,EQUITY,OCC.AX,OCC.AX,ORTHOCELL FPO,Orthocell Limited,1407801600,Australia/Sydney,AEST,36000000,0.365,2.0,buy,24817962,0.126,-9925147,562305,5.664,5.93,4243069,9.145,0.022,-0.19037001,-0.77841,3216914,15835941,14592580,3.424,0.75816,-2.33914,-2.42279,AUD,
7,Building 191,Murdoch University 90 South Street,Murdoch,WA,6150,Australia,61 8 9360 2888,61 8 9360 2899,https://orthocell.com,Biotechnology,Healthcare,"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.","{'maxAge': 1, 'name': 'Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D., MAICD', 'age': 59, 'title': 'Company Sec.', 'yearBorn': 1963, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.37,0.37,0.365,0.37,0.37,0.37,0.365,0.37,0.0,0.182807,-7.3,24914,24914,136196,114299,114299,0.36,0.375,0,0,73002192,0,0.32,0.505,17.205044,0.3799,0.3846125,0.0,0.0,AUD,47759964,-1.4725599,152706658,197303008,0.23173,0.02912,0.031,11.774194,1688083200,1719705600,1688083200,-6248181,-0.03,-0.05,11.256,-4.812,ASX,EQUITY,OCC.AX,OCC.AX,ORTHOCELL FPO,Orthocell Limited,1407801600,Australia/Sydney,AEST,36000000,0.365,2.0,buy,24817962,0.126,-9925147,562305,5.664,5.93,4243069,9.145,0.022,-0.19037001,-0.77841,3216914,15835941,14592580,3.424,0.75816,-2.33914,-2.42279,AUD,
